Operated by Ieldas Inc. · Independent methodology · Affiliate-supported. Read our ownership & funding disclosure and how every figure is verified.
GLP1ProviderFinderUS price records
HomeCompare › MEDVi vs Yucca Health

Head-to-head · computed 2026-08-11

MEDVi vs Yucca Health

MEDVi: MEDVi advertises a $179 semaglutide start that tiers to $299 at maintenance; tirzepatide is $399 flat. Yucca Health: Yucca pairs no-membership pricing with dose-flat rates: $146/month semaglutide and $258/month tirzepatide, both all-in.

Tirzepatide

MEDViYucca Health
All-in maintenance$399/mo$258/mo
Best plan rate$399/mo$258/mo
12-month total$4,788$3,096
StatusProvider-stated · 2026-08-05Provider-stated · 2026-08-05

The arithmetic

On the figures our desk holds, Yucca Health's $258 a month undercuts MEDVi's $399 by $141 a month at the 10 mg/wk maintenance basis — $1,692 across a year. Yucca Health's figure is provider-stated (captured 2026-08-05) and MEDVi's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.

MEDVi's tirzepatide ladder runs $399 a month billed monthly. Yucca Health's runs $258 a month billed monthly. On the twelve-month basis Yucca Health's $3,096 beats MEDVi's $4,788 by $1,692 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.

Semaglutide

MEDViYucca Health
All-in maintenance$299/mo$146/mo
Best plan rate$299/mo$146/mo
12-month total$3,588$1,752
StatusProvider-stated · 2026-08-05Provider-stated · 2026-08-05

The arithmetic

On the figures our desk holds, Yucca Health's $146 a month undercuts MEDVi's $299 by $153 a month at the 2.4 mg/wk maintenance basis — $1,836 across a year. Yucca Health's figure is provider-stated (captured 2026-08-05) and MEDVi's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.

MEDVi's semaglutide ladder runs $299 a month billed monthly. Yucca Health's runs $146 a month billed monthly. On the twelve-month basis Yucca Health's $1,752 beats MEDVi's $3,588 by $1,836 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.

Structure, side by side

MEDVi

  • MembershipNone
  • Dose policyTiered on semaglutide; tirzepatide flat
  • CommitmentMonth-to-month
  • CancellationCancel before renewal
  • PharmacyPartner pharmacies

Yucca Health

  • MembershipNone
  • Dose policyDose-flat
  • CommitmentMonth-to-month
  • CancellationCancel before renewal
  • PharmacyPartner 503A pharmacies

What our desk is watching on each

MEDVi: Start-vs-maintenance spread on semaglutide; compare on maintenance.

Yucca Health: Provider-stated from published pages; checkout capture pending.

Questions people ask

Is MEDVi or Yucca Health cheaper in 2026?

The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.

What does MEDVi vs Yucca Health miss that checkout will show?

Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.

Why do you compare at the maintenance dose instead of the starting dose?

Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.

What do MEDVi and Yucca Health cost over a full year of tirzepatide?

On the plans our database holds, a year of tirzepatide runs $4,788 at MEDVi and $3,096 at Yucca Health — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.

Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: MEDVi · Yucca Health. Official sites: MEDVi ↗ · Yucca Health ↗. Nothing here is medical advice.